Cargando…
Small molecule correctors divert CFTR-F508del from ERAD by stabilizing sequential folding states
Over 80% of people with cystic fibrosis (CF) carry the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride ion channel at the apical plasma membrane (PM) of epithelial cells. F508del impairs CFTR folding causing it to be destroyed by endoplasmic reticulum a...
Autores principales: | Riepe, Celeste, Wąchalska, Magda, Deol, Kirandeep K., Amaya, Anais K., Porteus, Matthew H., Olzmann, James A., Kopito, Ron R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515913/ https://www.ncbi.nlm.nih.gov/pubmed/37745470 http://dx.doi.org/10.1101/2023.09.15.556420 |
Ejemplares similares
-
Correctors modify the bicarbonate permeability of F508del-CFTR
por: Fiore, Michele, et al.
Publicado: (2020) -
Extracellular phosphate enhances the function of F508del-CFTR rescued by CFTR correctors
por: Saint-Criq, Vinciane, et al.
Publicado: (2021) -
Functional Rescue of F508del-CFTR Using Small Molecule Correctors
por: Molinski, Steven, et al.
Publicado: (2012) -
Constrained Bithiazoles: Small
Molecule Correctors
of Defective ΔF508–CFTR Protein Trafficking
por: Coffman, Keith C., et al.
Publicado: (2014) -
Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domain
por: Odolczyk, Norbert, et al.
Publicado: (2013)